login

Understanding pluripotency--how embryonic stem cells keep their options open

Molecular Human ReproductionPublished 20 August 2008
Brett V. Johnson, Norihisa Shindo, Peter D. Rathjen, Joy Rathjen, Rebecca A. Keough
Citations30
SJR quartileQ1
SJR score1.20
SNIP0.87

TL;DR

Combination of controlled differentiation with ground-breaking technologies for the reversal of somatic cells to an ES cell-like state promise the generation of patient-derived pluripotent cell lines for the treatment of disease in the future.

Abstract

Embryonic stem (ES) cells have the capacity to proliferate indefinitely in culture while maintaining the ability to differentiate to form any of the cells of the body. This unique combination of functions suggests that these cells could provide a potentially unlimited source of differentiated cells for the treatment of disease and aging. Understanding the molecular processes that underpin these functions in ES cells will allow us to harness their potential and develop strategies that control their differentiation. Combination of controlled differentiation with ground-breaking technologies for the reversal of somatic cells to an ES cell-like state promise the generation of patient-derived pluripotent cell lines for the treatment of disease in the future.

Keywords

Biochemistry, Genetics and Molecular Biology